Overexpression of iNOS and COX-2 in numerous human carcinomas resulted in the release of large amounts of NO and prostaglandins (PGs), but their exact source could not be clarified because both cancer cells and stromal cells can lead to the release of metabolites and their potential pathogenic role in tumor growth remains to be fully elucidated. This evidence concerns the gene NOS2 and cancer.